Global Immunotherapy Market Growth (Status and Outlook) 2024-2030

September 2024 | 102 pages | ID: G43A1F091B48EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Immunotherapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Immunotherapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Immunotherapy market. Immunotherapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immunotherapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immunotherapy market.

Key Features:

The report on Immunotherapy market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Immunotherapy market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibodies, Therapeutic Vaccines), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immunotherapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Immunotherapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Immunotherapy industry. This include advancements in Immunotherapy technology, Immunotherapy new entrants, Immunotherapy new investment, and other innovations that are shaping the future of Immunotherapy.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immunotherapy market. It includes factors influencing customer ' purchasing decisions, preferences for Immunotherapy product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immunotherapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immunotherapy market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immunotherapy market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immunotherapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immunotherapy market.

Market Segmentation:

Immunotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Monoclonal Antibodies
• Therapeutic Vaccines
• Checkpoint Inhibitors
• Non-Specific Immunotherapy

Segmentation by application

• Oncology
• Inflammation
• Central Nervous System
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbvie
• Amgen, Inc.
• Biogen
• Bristol-Myers Squibb
• Celgene
• Johnson & Johnson
• Merck
• Novartis
• Pfizer
• Roche

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Immunotherapy Market Size 2019-2030
  2.1.2 Immunotherapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Immunotherapy Segment by Type
  2.2.1 Monoclonal Antibodies
  2.2.2 Therapeutic Vaccines
  2.2.3 Checkpoint Inhibitors
  2.2.4 Non-Specific Immunotherapy
2.3 Immunotherapy Market Size by Type
  2.3.1 Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Immunotherapy Market Size Market Share by Type (2019-2024)
2.4 Immunotherapy Segment by Application
  2.4.1 Oncology
  2.4.2 Inflammation
  2.4.3 Central Nervous System
  2.4.4 Others
2.5 Immunotherapy Market Size by Application
  2.5.1 Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Immunotherapy Market Size Market Share by Application (2019-2024)

3 IMMUNOTHERAPY MARKET SIZE BY PLAYER

3.1 Immunotherapy Market Size Market Share by Players
  3.1.1 Global Immunotherapy Revenue by Players (2019-2024)
  3.1.2 Global Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IMMUNOTHERAPY BY REGIONS

4.1 Immunotherapy Market Size by Regions (2019-2024)
4.2 Americas Immunotherapy Market Size Growth (2019-2024)
4.3 APAC Immunotherapy Market Size Growth (2019-2024)
4.4 Europe Immunotherapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Immunotherapy Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Immunotherapy Market Size by Country (2019-2024)
5.2 Americas Immunotherapy Market Size by Type (2019-2024)
5.3 Americas Immunotherapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Immunotherapy Market Size by Region (2019-2024)
6.2 APAC Immunotherapy Market Size by Type (2019-2024)
6.3 APAC Immunotherapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Immunotherapy by Country (2019-2024)
7.2 Europe Immunotherapy Market Size by Type (2019-2024)
7.3 Europe Immunotherapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Immunotherapy by Region (2019-2024)
8.2 Middle East & Africa Immunotherapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Immunotherapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IMMUNOTHERAPY MARKET FORECAST

10.1 Global Immunotherapy Forecast by Regions (2025-2030)
  10.1.1 Global Immunotherapy Forecast by Regions (2025-2030)
  10.1.2 Americas Immunotherapy Forecast
  10.1.3 APAC Immunotherapy Forecast
  10.1.4 Europe Immunotherapy Forecast
  10.1.5 Middle East & Africa Immunotherapy Forecast
10.2 Americas Immunotherapy Forecast by Country (2025-2030)
  10.2.1 United States Immunotherapy Market Forecast
  10.2.2 Canada Immunotherapy Market Forecast
  10.2.3 Mexico Immunotherapy Market Forecast
  10.2.4 Brazil Immunotherapy Market Forecast
10.3 APAC Immunotherapy Forecast by Region (2025-2030)
  10.3.1 China Immunotherapy Market Forecast
  10.3.2 Japan Immunotherapy Market Forecast
  10.3.3 Korea Immunotherapy Market Forecast
  10.3.4 Southeast Asia Immunotherapy Market Forecast
  10.3.5 India Immunotherapy Market Forecast
  10.3.6 Australia Immunotherapy Market Forecast
10.4 Europe Immunotherapy Forecast by Country (2025-2030)
  10.4.1 Germany Immunotherapy Market Forecast
  10.4.2 France Immunotherapy Market Forecast
  10.4.3 UK Immunotherapy Market Forecast
  10.4.4 Italy Immunotherapy Market Forecast
  10.4.5 Russia Immunotherapy Market Forecast
10.5 Middle East & Africa Immunotherapy Forecast by Region (2025-2030)
  10.5.1 Egypt Immunotherapy Market Forecast
  10.5.2 South Africa Immunotherapy Market Forecast
  10.5.3 Israel Immunotherapy Market Forecast
  10.5.4 Turkey Immunotherapy Market Forecast
  10.5.5 GCC Countries Immunotherapy Market Forecast
10.6 Global Immunotherapy Forecast by Type (2025-2030)
10.7 Global Immunotherapy Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Abbvie
  11.1.1 Abbvie Company Information
  11.1.2 Abbvie Immunotherapy Product Offered
  11.1.3 Abbvie Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Abbvie Main Business Overview
  11.1.5 Abbvie Latest Developments
11.2 Amgen, Inc.
  11.2.1 Amgen, Inc. Company Information
  11.2.2 Amgen, Inc. Immunotherapy Product Offered
  11.2.3 Amgen, Inc. Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Amgen, Inc. Main Business Overview
  11.2.5 Amgen, Inc. Latest Developments
11.3 Biogen
  11.3.1 Biogen Company Information
  11.3.2 Biogen Immunotherapy Product Offered
  11.3.3 Biogen Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Biogen Main Business Overview
  11.3.5 Biogen Latest Developments
11.4 Bristol-Myers Squibb
  11.4.1 Bristol-Myers Squibb Company Information
  11.4.2 Bristol-Myers Squibb Immunotherapy Product Offered
  11.4.3 Bristol-Myers Squibb Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Bristol-Myers Squibb Main Business Overview
  11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Celgene
  11.5.1 Celgene Company Information
  11.5.2 Celgene Immunotherapy Product Offered
  11.5.3 Celgene Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Celgene Main Business Overview
  11.5.5 Celgene Latest Developments
11.6 Johnson & Johnson
  11.6.1 Johnson & Johnson Company Information
  11.6.2 Johnson & Johnson Immunotherapy Product Offered
  11.6.3 Johnson & Johnson Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Johnson & Johnson Main Business Overview
  11.6.5 Johnson & Johnson Latest Developments
11.7 Merck
  11.7.1 Merck Company Information
  11.7.2 Merck Immunotherapy Product Offered
  11.7.3 Merck Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Merck Main Business Overview
  11.7.5 Merck Latest Developments
11.8 Novartis
  11.8.1 Novartis Company Information
  11.8.2 Novartis Immunotherapy Product Offered
  11.8.3 Novartis Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Novartis Main Business Overview
  11.8.5 Novartis Latest Developments
11.9 Pfizer
  11.9.1 Pfizer Company Information
  11.9.2 Pfizer Immunotherapy Product Offered
  11.9.3 Pfizer Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Pfizer Main Business Overview
  11.9.5 Pfizer Latest Developments
11.10 Roche
  11.10.1 Roche Company Information
  11.10.2 Roche Immunotherapy Product Offered
  11.10.3 Roche Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Roche Main Business Overview
  11.10.5 Roche Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Immunotherapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Therapeutic Vaccines
Table 4. Major Players of Checkpoint Inhibitors
Table 5. Major Players of Non-Specific Immunotherapy
Table 6. Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Immunotherapy Market Size Market Share by Type (2019-2024)
Table 9. Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Immunotherapy Market Size Market Share by Application (2019-2024)
Table 12. Global Immunotherapy Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Immunotherapy Revenue Market Share by Player (2019-2024)
Table 14. Immunotherapy Key Players Head office and Products Offered
Table 15. Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Immunotherapy Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Immunotherapy Market Size Market Share by Regions (2019-2024)
Table 20. Global Immunotherapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Immunotherapy Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Immunotherapy Market Size Market Share by Country (2019-2024)
Table 24. Americas Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Immunotherapy Market Size Market Share by Type (2019-2024)
Table 26. Americas Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Immunotherapy Market Size Market Share by Application (2019-2024)
Table 28. APAC Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Immunotherapy Market Size Market Share by Region (2019-2024)
Table 30. APAC Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Immunotherapy Market Size Market Share by Type (2019-2024)
Table 32. APAC Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Immunotherapy Market Size Market Share by Application (2019-2024)
Table 34. Europe Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Immunotherapy Market Size Market Share by Country (2019-2024)
Table 36. Europe Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Immunotherapy Market Size Market Share by Type (2019-2024)
Table 38. Europe Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Immunotherapy Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Immunotherapy Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Immunotherapy Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Immunotherapy Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Immunotherapy
Table 47. Key Market Challenges & Risks of Immunotherapy
Table 48. Key Industry Trends of Immunotherapy
Table 49. Global Immunotherapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Immunotherapy Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Immunotherapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Immunotherapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbvie Details, Company Type, Immunotherapy Area Served and Its Competitors
Table 54. Abbvie Immunotherapy Product Offered
Table 55. Abbvie Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbvie Main Business
Table 57. Abbvie Latest Developments
Table 58. Amgen, Inc. Details, Company Type, Immunotherapy Area Served and Its Competitors
Table 59. Amgen, Inc. Immunotherapy Product Offered
Table 60. Amgen, Inc. Main Business
Table 61. Amgen, Inc. Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Amgen, Inc. Latest Developments
Table 63. Biogen Details, Company Type, Immunotherapy Area Served and Its Competitors
Table 64. Biogen Immunotherapy Product Offered
Table 65. Biogen Main Business
Table 66. Biogen Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Biogen Latest Developments
Table 68. Bristol-Myers Squibb Details, Company Type, Immunotherapy Area Served and Its Competitors
Table 69. Bristol-Myers Squibb Immunotherapy Product Offered
Table 70. Bristol-Myers Squibb Main Business
Table 71. Bristol-Myers Squibb Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Bristol-Myers Squibb Latest Developments
Table 73. Celgene Details, Company Type, Immunotherapy Area Served and Its Competitors
Table 74. Celgene Immunotherapy Product Offered
Table 75. Celgene Main Business
Table 76. Celgene Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Celgene Latest Developments
Table 78. Johnson & Johnson Details, Company Type, Immunotherapy Area Served and Its Competitors
Table 79. Johnson & Johnson Immunotherapy Product Offered
Table 80. Johnson & Johnson Main Business
Table 81. Johnson & Johnson Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Johnson & Johnson Latest Developments
Table 83. Merck Details, Company Type, Immunotherapy Area Served and Its Competitors
Table 84. Merck Immunotherapy Product Offered
Table 85. Merck Main Business
Table 86. Merck Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Merck Latest Developments
Table 88. Novartis Details, Company Type, Immunotherapy Area Served and Its Competitors
Table 89. Novartis Immunotherapy Product Offered
Table 90. Novartis Main Business
Table 91. Novartis Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Novartis Latest Developments
Table 93. Pfizer Details, Company Type, Immunotherapy Area Served and Its Competitors
Table 94. Pfizer Immunotherapy Product Offered
Table 95. Pfizer Main Business
Table 96. Pfizer Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Pfizer Latest Developments
Table 98. Roche Details, Company Type, Immunotherapy Area Served and Its Competitors
Table 99. Roche Immunotherapy Product Offered
Table 100. Roche Main Business
Table 101. Roche Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Roche Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immunotherapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Immunotherapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Immunotherapy Sales Market Share by Country/Region (2023)
Figure 8. Immunotherapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Immunotherapy Market Size Market Share by Type in 2023
Figure 10. Immunotherapy in Oncology
Figure 11. Global Immunotherapy Market: Oncology (2019-2024) & ($ Millions)
Figure 12. Immunotherapy in Inflammation
Figure 13. Global Immunotherapy Market: Inflammation (2019-2024) & ($ Millions)
Figure 14. Immunotherapy in Central Nervous System
Figure 15. Global Immunotherapy Market: Central Nervous System (2019-2024) & ($ Millions)
Figure 16. Immunotherapy in Others
Figure 17. Global Immunotherapy Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Immunotherapy Market Size Market Share by Application in 2023
Figure 19. Global Immunotherapy Revenue Market Share by Player in 2023
Figure 20. Global Immunotherapy Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 22. APAC Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 23. Europe Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 25. Americas Immunotherapy Value Market Share by Country in 2023
Figure 26. United States Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Immunotherapy Market Size Market Share by Region in 2023
Figure 31. APAC Immunotherapy Market Size Market Share by Type in 2023
Figure 32. APAC Immunotherapy Market Size Market Share by Application in 2023
Figure 33. China Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Immunotherapy Market Size Market Share by Country in 2023
Figure 40. Europe Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 41. Europe Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 42. Germany Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Immunotherapy Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 56. APAC Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 57. Europe Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 59. United States Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 60. Canada Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 63. China Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 64. Japan Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 65. Korea Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 67. India Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 68. Australia Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 69. Germany Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 70. France Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 71. UK Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 72. Italy Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 73. Russia Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 74. Spain Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 77. Israel Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 80. Global Immunotherapy Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Immunotherapy Market Size Market Share Forecast by Application (2025-2030)